MICHAEL JAMES OVERMAN to Dasatinib
This is a "connection" page, showing publications MICHAEL JAMES OVERMAN has written about Dasatinib.
Connection Strength
0.135
-
Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer. Clin Cancer Res. 2017 Aug 01; 23(15):4146-4154.
Score: 0.108
-
Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer. Clin Cancer Res. 2017 Aug 15; 23(16):4578-4591.
Score: 0.027